Gaba-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion

Journal of Neurochemistry

Volumn 82, Issue 3, 2002, Pages 666-673

  Schroeder, J A ^a,b   Schneider, J S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

DALA; Enkephalin; GABA; Globus pallidus; Microdialysis; Parkinsonism

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ENKEPHALIN RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; METENKEPHALIN; OPIATE; POTASSIUM ION;

4 AMINOBUTYRIC ACID RELEASE; AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; EXTRACELLULAR FLUID; GLOBUS PALLIDUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STRIATONIGRAL DEGENERATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; CATS; DISEASE MODELS, ANIMAL; ENKEPHALIN, METHIONINE; EXTRACELLULAR SPACE; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; MALE; MICRODIALYSIS; NALOXONE; NARCOTIC ANTAGONISTS; PARKINSONIAN DISORDERS; POTASSIUM; RECOVERY OF FUNCTION;

ANIMALIA; FELIS CATUS; PARKINSONIA;

EID: 0036326034     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01010.x     Document Type: Article

References (52)

1. The functional anatomy of basal ganglia circuits: Neural substrates of parallel processing
2. Dopaminergic involvement in locomotion elicited from the VP/substantia innominata
3. Quantitative in situ hybridization evidence for differential regulation of preproenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: Effects of unilateral intrastriatal injections of 6-hydroxydopamine
4. 2 receptor inhibition of calcium channels in acutely-dissociated locus coeruleus neurones
5. Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity
6. Opioid inhibition of GABA release from pre-synaptic terminals of rat hippocampal interneurons
7. +2 channel currents of acutely dissociated rat periaqueductal grey neurons
8. μ-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR1
9. Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: Correlation with degree of parkinsonian symptoms
10. Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus
11. Neurobiology of opiate abuse
12. Involvement of cholinergic neurons in the release of dopamine elicited by stimulation of mu-opioid receptors in striatum
13. +2 channels in the calyx pre-synaptic terminal of the embryonic chick ciliary ganglion
14. Effects of enkephalin and morphine on rat globus pallidus neurons
15. Tissue and microdialysate changes after repeated and permanent probe implantation in the striatum of freely moving rats
16. Glycine and GABA (A) receptormediated synaptic transmission in rat substantia gelatinosa: Inhibition by μ-opioid and GABA (B) agonists
17. Pre-proenkephalin mRNA and methionine-enkephalin increase in mouse striatum after 1-methyl4-phenyl-1,2,3,6-tetrahydropyridine treatment
18. Ventral pallidal microinjection of receptor selective opioid agonists produce differential effects on circling and locomotor activity in rats
19. Pre- and post-synaptic inhibition by opioids in rat striatum
20. Morphine modulation of GABA and glutamate-induced changes of ventral pallidal neuronal activity
21. Effects of dopamine on spontaneous and evoked activity of caudate neurons
22. +2 channels in the rat periaqueductal gray neurons by μ-type opioid agonist
23. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus
24. Spontaneous unit activity in the globus pallidus following cumulative injections of morphine in phenobarbital- or chloral hydrate-anesthetized rats
25. Long-term effects of dopamine-depleting brain lesions on the spontaneous activity of type II striatal neurons: Relation to behavioral recovery
26. Dopaminergic neurons of the substantia nigra modulate pre-proenkephalin A gene expression in rat striatal neurons
27. Pre-synaptic actions of opioids
28. 2]-MetEnkephalinamide: A potent long-lasting synthetic pentapeptide analgesic
29. Selective opioid agonists modulate afferent transmission in the rat nucleus tractus solitarius
30. Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: An intracerebral microdialysis study of gamma-aminobutryic acid in the lateral segment of the globus pallidus
31. Response of caudate neurons to stimulation of intrinsic and peripheral afferents in normal, symptomatic, and recovered MPTP-treated cats
32. Alterations in pallidal neuronal responses to peripheral sensory and striatal stimulation in symptomatic and recovered parkinsonian cats
33. Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatisation
34. Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats
35. Functional recovery from experimental parkinsonism in cats is accomplished by partial recovery of extracellular but not tissue levels of dopamine in the dorsolateral caudate nucleus
36. Volume transmission oif dopamine over large distances may contribute to recovery from experimental parkinsonism
37. Differential recovery of sensorimotor function in GM 1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: Partial striatal dopaminergic reinnervation vs. neurochemical compensation
38. Production of a parkisonian-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Behavior, histology and biochemistry
39. Striatal enkephalin gene expression does not reflect parkinsonian signs
40. Alterations in expression of messenger RNAs encoding two isoforms of glutamic acid decarboxylase in globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental parkinsonism
41. Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with nigrostiatal pathway lesions
42. Gamma-amino butyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat
43. Calcium ions, acitve zones and synaptic transmitter release
44. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates
45. Presynaptic μ and ? opioid receptor modulation of GABA (A) IPSCs in the rat globus pallidus in vitro
46. Striatal met-enkephalin concentration increases following nigrostriatal denervation
47. Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis
48. How opioids inhibit GABA-mediated nerotransmission
49. Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals
50. Increase of enkephalin and decrease of substance P immunoreactivity in the striatum of the rat after midbrain 6-hdroxydopamine lesions
51. Methodology of microdialysis of neostriatum in hemiparkinsonian nonhuman primates